1. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial. Issue 10246 (25th July 2020) Authors: Burmester, Gerd R; Buttgereit, Frank; Bernasconi, Corrado; Álvaro-Gracia, Jose M; Castro, Nidia; Dougados, Maxime; Gabay, Cem; van Laar, Jacob M; Nebesky, Jan Michael; Pethoe-Schramm, Attila; Salvarani, Carlo; Donath, Marc Y; John, Markus R Journal: Lancet Issue: Volume 396:Issue 10246(2020) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0030 RANDOMIZED CONTROLLED 24-WEEK TRIAL EVALUATING THE SAFETY AND EFFICACY OF BLINDED TAPERING VERSUS CONTINUATION OF LONG-TERM PREDNISONE (5 MG/D) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ACHIEVED LOW DISEASE ACTIVITY OR REMISSION ON TOCILIZUMAB. (June 2019) Authors: Burmester, Gerd Rüdiger; Buttgereit, Frank; Bernasconi, Corrado; Alvaro-Gracia, Jose-Maria; Castro, Nidia; Dougados, Maxime; Gabay, Cem; Jacob, M.; Laar, van; Michael Nebesky, J.; Pethoe-Schramm, Attila; Salvarani, Carlo; Donath, Marc Y.; John, Markus R. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗